Mechanisms of antifungal drug resistance in Candida dubliniensis (Q37762556)

22 August 2017

1 reference

title

Mechanisms of antifungal drug resistance in Candida dubliniensis (English)

1 reference

antifungal drug resistance

22 August 2017

1 reference

Candida dubliniensis

1 reference

Brenda A McManus

3

0 references

Gary P. Moran

object named as

Gary P Moran

series ordinal

2

0 references

Derek J. Sullivan

object named as

Derek J Sullivan

series ordinal

4

0 references

David C. Coleman

object named as

David C Coleman

series ordinal

1

0 references

publication date

1 June 2010

1 reference

22 August 2017

15

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

22 August 2017

5

1 reference

22 August 2017

935-949

1 reference

22 August 2017

6

1 reference

Oral Candida in HIV infection and AIDS: new perspectives/new approaches

22 August 2017

1 reference

Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species

21 January 2018

1 reference

Management and outcome of bloodstream infections due to Candida species in England and Wales

21 January 2018

1 reference

Recent experience with fungaemia: change in species distribution and azole resistance

21 January 2018

1 reference

The changing face of epidemiology of invasive fungal disease in Europe

21 January 2018

1 reference

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals

21 January 2018

1 reference

Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients

21 January 2018

1 reference

21 January 2018

1 reference

Isolation of C. dubliniensis from insulin-using diabetes mellitus patients.

21 January 2018

1 reference

Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients

21 January 2018

1 reference

Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections

21 January 2018

1 reference

Candida dubliniensis candidaemia in an HIV-positive patient in Ireland

21 January 2018

1 reference

Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole

21 January 2018

1 reference

Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo

21 January 2018

1 reference

High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer

21 January 2018

1 reference

Candida dubliniensis at a University Hospital in Saudi Arabia

21 January 2018

1 reference

Isolation of Candida dubliniensis in an aboriginal community in Ontario, Canada

21 January 2018

1 reference

Prevalence of Candida species, including Candida dubliniensis, in Singapore

21 January 2018

1 reference

Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans

21 January 2018

1 reference

High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina

21 January 2018

1 reference

First reported case of endocarditis caused by Candida dubliniensis

21 January 2018

1 reference

The first clinical isolates of Candida dubliniensis in Slovakia.

21 January 2018

1 reference

Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient.

21 January 2018

1 reference

Candida dubliniensis: ten years on.

21 January 2018

1 reference

Initial Candida dubliniensis isolate in Candida spp. positive haemocultures in Turkey between 2001 and 2004.

21 January 2018

1 reference

Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count

21 January 2018

1 reference

Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans

21 January 2018

1 reference

Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods

21 January 2018

1 reference

Oral distribution of Candida species and presence of oral lesions in Brazilian leprosy patients under multidrug therapy

21 January 2018

1 reference

Candida dubliniensis: first identification in Sfax Hospital, Tunisia

21 January 2018

1 reference

Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences

21 January 2018

1 reference

Candida dubliniensis: phylogeny and putative virulence factors

21 January 2018

1 reference

Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar

21 January 2018

1 reference

Comparison of Candida dubliniensis and C. albicans based on polar lipid composition

21 January 2018

1 reference

Differentiation of Candida dubliniensis from Candida albicans on Pal's agar

21 January 2018

1 reference

Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis.

21 January 2018

1 reference

Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans

21 January 2018

1 reference

Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.

21 January 2018

1 reference

Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis

21 January 2018

1 reference

Genome-wide gene expression profiling and a forward genetic screen show that differential expression of the sodium ion transporter Ena21 contributes to the differential tolerance of Candida albicans and Candida dubliniensis to osmotic stress.

21 January 2018

1 reference

Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model

21 January 2018

1 reference

Resistance of Candida species to fluconazole

21 January 2018

1 reference

Update on antifungal resistance

21 January 2018

1 reference

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

21 January 2018

1 reference

Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada

21 January 2018

1 reference

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis

21 January 2018

1 reference

Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis

21 January 2018

1 reference

The genetic basis of fluconazole resistance development in Candida albicans

21 January 2018

1 reference

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

21 January 2018

1 reference

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

21 January 2018

1 reference

Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

21 January 2018

1 reference

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

21 January 2018

1 reference

Candida lusitaniae: a cause of breakthrough fungemia in cancer patients

21 January 2018

1 reference

Candida lusitaniae infections in the era of fluconazole availability

21 January 2018

1 reference

Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

21 January 2018

1 reference

Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.

21 January 2018

1 reference

Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting

21 January 2018

1 reference

Molecular phylogenetics of Candida albicans.

21 January 2018

1 reference

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis

21 January 2018

1 reference

Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait

21 January 2018

1 reference

In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.

21 January 2018

1 reference

Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans

21 January 2018

1 reference

Molecular mechanisms of primary resistance to flucytosine in Candida albicans

21 January 2018

1 reference

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

21 January 2018

1 reference

Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina

21 January 2018

1 reference

In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

21 January 2018

1 reference

Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

21 January 2018

1 reference

Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina

21 January 2018

1 reference

Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.

21 January 2018

1 reference

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

21 January 2018

1 reference

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

21 January 2018

1 reference

MDR1-mediated drug resistance in Candida dubliniensis

21 January 2018

1 reference

The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance

21 January 2018

1 reference

Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression

21 January 2018

1 reference

Genetic differences between avian and human isolates of Candida dubliniensis

21 January 2018

1 reference

Aneuploidy and isochromosome formation in drug-resistant Candida albicans

21 January 2018

1 reference

Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates

21 January 2018

1 reference

Microevolutionary changes and chromosomal translocations are more frequent at RPS loci in Candida dubliniensis than in Candida albicans.

21 January 2018

1 reference

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

21 January 2018

1 reference

Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents

21 January 2018

1 reference

Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients

21 January 2018

1 reference

The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans

21 January 2018

1 reference

Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains

21 January 2018

1 reference

Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains

21 January 2018

1 reference

Molecular mechanisms of itraconazole resistance in Candida dubliniensis

21 January 2018

1 reference

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

21 January 2018

1 reference

Regulation of multidrug resistance in pathogenic fungi

21 January 2018

1 reference

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents

21 January 2018

1 reference

Activity of micafungin against Candida biofilms

21 January 2018

1 reference

Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing

21 January 2018

1 reference

Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans

21 January 2018

1 reference

Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.10.51

1 reference

22 August 2017

1 reference

PubMed ID

20521937